Pharmacists in South San Francisco, California
111 Pharmacists found in South San Francisco
Dr. Matthew Lee, PHARM.D.
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
701 Gateway Blvd, South San Francisco, CA 94080
650-616-2088
Dr. Matthew Chandler, PHARM.D.
Pharmacist
1200 El Camino Real, South San Francisco, CA 94080
650-742-2486
Melissa Marsinko, PHARM.D.
Pharmacist
1200 El Camino Real, South San Francisco, CA 94080
650-742-2486
Michelle Yee, PHARM. D.
Pharmacist
1200 El Camino Real, 3rd Floor Inpatient Pharmacy, South San Francisco, CA 94080
650-742-2486
Michelle Ju Hyun Park, PHARM.D.
Pharmacist
1200 El Camino Real, South San Francisco, CA 94080
650-742-3251
Dr. Misuzu Naganuma, PHARM.D.
Pharmacist
161 S Spruce Ave, Ste 200, South San Francisco, CA 94080
650-360-5358
Nicholas John Ratto, PHARM.D.
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
701 Gateway Blvd, Suite 600, South San Francisco, CA 94080
650-228-9945
Dr. Nora Wong Choi
Pharmacist
1600 El Camino Real, South San Francisco, CA 94080
650-757-3002 650-757-3009
Patrick K Lam, PHARM.D.
Pharmacist
1200 El Camino Real, Inpatient Pharmacy, 3rd Flr Tower, South San Francisco, CA 94080
650-742-2486 650-742-2632
Dr. Pauline Wai-sze Chan, PHARM D
Pharmacist
3760 Palos Verdes Way, South San Francisco, CA 94080
415-205-7366
Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.